It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Copyright © 2020 MarketWatch, Inc. All rights reserved. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.42 and has seen 444,665 shares traded in the last trading session. Antares Pharma Inc. [ATRS]: An insightful look at the core fundamentals. Antares Pharma Inc.’s Net Margin is presently recorded at -1.64. Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Antares Pharma Inc is a specialty pharmaceutical company. The 12-month stock price forecast is 6.25, which is an increase of 56.64% from the latest price. The 1-year high price for the company’s stock is recorded $4.65 on 01/02/20, with the lowest value was $1.60 for the same time period, recorded on 03/23/20. There are currently no items in this Watchlist. Antares Pharma Inc (ATRS) stock has gained 4.73% while the S&P 500 is lower by -0.17% as of 10:42 AM on Monday, Aug 31.
Historical and current end-of-day data provided by FACTSET. Antares Pharma Inc. [ATRS]: An insightful look at the core fundamentals. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. Antares Pharma, Inc. Common Stock (ATRS) Nasdaq 8/3/2020. ET by Tomi Kilgore Antares Pharma stock … Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Over the past year the S&P 500 is higher by 20.50% while ATRS is lower by -8.28%. The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. A recent spot check on the stock’s support and resistance revealed that the publicly-traded Antares Pharma Inc. (NASDAQ: ATRS) shares are trading at a price close to -3.75% lower than its 90-day high. Antares Pharma Inc. had a pretty Dodgy run when it comes to the market performance. Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. On the other hand, the stock is +28.46% away from its low in the 90-day period. A company profile for Antares Pharma, Inc, including a description, key executives, stock price history and more. Stock analysis for Antares Pharma Inc (AIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The company, currently valued at $475.02 Million, closed the last trade at $2.85 per share which meant it lost -$0.01 on the day or -0.35% during that session. Find the latest Antares Pharma, Inc. (ATRS) stock discussions in Yahoo Finance's forum. ATRS has gained $0.13 from the previous closing price of $2.75 on volume of 318,338 shares. All rights reserved. Stock analysis for Antares Pharma Inc (AIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Antares Pharma Inc stock news. View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Currency in USD, Trade prices are not sourced from all markets. Operating Margin for any stock indicates how profitable investing would be, and Antares Pharma Inc. [ATRS] shares currently have an operating margin of +0.80 and a Gross Margin at +58.97. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. 2019-10-18 seekingalpha.com - The share price action of Antares Pharma, Inc. (ATRS) (Medical Instruments & Supplies Firm) since late April definitely brings opportunities to the table for short-term traders. This browser is no longer supported at MarketWatch. View Antares Pharma, Inc. ATRS investment & stock information. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. 5. View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Antares Pharma Inc. had a pretty Dodgy run when it comes to the market performance. Antares Pharma's stock plunges 40% premarket toward 8-mo. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.42 and has seen 444,665 shares traded in the last trading session. The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. Antares Pharma Inc stock news. Antares Pharma Inc. (ATRS) full year performance was -16.99%. Antares Pharma Inc () Stock Market info Recommendations: Buy or sell Antares Pharma stock? This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Create a list of the investments you want to track. Share your opinion and gain insight from other stock traders and investors. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Real-time trade and investing ideas on Antares Pharma Inc. ATRS from the largest community of traders and investors. Antares Pharma, Inc. Common Stock (ATRS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Have Watchlists? Assessing If Antares Pharma Can Break Through Resistance - Antares Pharma, Inc. (NASDAQ:ATRS) | Seeking Alpha. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. H.C. Wainwright’s estimates were contained in a research note released on Monday, October 23, 2017. Online Stock Comparison - Compare Antares Pharma, Inc. (ATRS) to four other stocks with NASDAQ.com's stock comparison tool. All quotes are in local exchange time. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Antares Pharma Inc. Barron's 12/3/2020. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. low after FDA letter late Thursday, Bearish bets against Tesla stock have fallen to a record low, data provider says, Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-pack, Stocks close higher for fifth straight session as Dow reclaims 25,000-level, Antares Pharma, Amag Pharma shares soar premarket after FDA approves auto injector, Stock market ends, day week with a gain; Nasdaq logs 57th all-time high, Antares Pharma stock plunges more than 30% after FDA letter, Antares sees positive results from arthritis study, Wednesday’s biggest gaining and declining stocks, Major U.S. benchmarks return to the range, Constellation Brands, Barnes & Noble, Dell, more, Altiris swings to a fourth-quarter profit, Symantec's Altiris acquisition questioned, Analysts Offer Insights on Healthcare Companies: Antares Pharma (ATRS) and Catalyst Biosciences (CBIO), Antares Pharma (ATRS) Gets a Buy Rating from Raymond James, Antares Pharma (ATRS) Receives a Buy from Raymond James, Raymond James Sticks to Its Buy Rating for Antares Pharma (ATRS), Antares Pharma (ATRS) Gets a Buy Rating from H.C. Wainwright, Wall Street Analysts Are Bullish on Top Healthcare Picks, Raymond James Keeps a Buy Rating on Antares Pharma (ATRS), Antares Pharma (ATRS) Q3 Earnings Match Estimates, Raymond James Remains a Buy on Antares Pharma (ATRS), Antares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release. Cookie Notice. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. For the best MarketWatch.com experience, please update to a modern browser. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Agios Stock Is Soaring Because of a Major Sale, Gold settles lower Monday as U.S. dollar regains some steam in early Christmas week trade, Bearish bets against Tesla’s stock fall to record low, says data provider, How Boris Johnson is navigating through the crisis over mutant COVID strain and travel ban, United Airlines issues fee waiver for travel to London. ATRS, Antares Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Subscribe to Premium to view Fair Value for ATRS, Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. ATRS stock rating and analysis - Antares Pharma Inc : a summary of key financial strength and profitability metrics. By using this site you agree to the
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. By Samuel Moore. Antares Pharma Inc. (ATRS) full year performance was -16.99%. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real Time Price. In the following paragraphs, we find out […], 有超過 10,000 名教師任你選擇，讓你根據自己的目標和興趣進行一對一課程，更可按堂收費，自訂學習方式！. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Antares Pharma Inc. SUITE 300, 100 PRINCETON SOUTH EWING NJ 8628 P: +1609.3593020 F: +1302.6555049 Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. © 2020 Verizon Media. Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Antares Pharma, Inc., which has a market valuation of $525.7 Million as of writing, is expected to release its quarterly earnings report on 44140. ATRS, Antares Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Intraday data delayed at least 15 minutes or per exchange requirements. Price Target Intraday Data provided by FACTSET and subject to terms of use. A high-level overview of Antares Pharma, Inc. (ATRS) stock. After the company reported mixed first-quarter financial results that were better than expected on the top line and worse than expected on the bottom line, shares in Antares Pharma … By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites. Antares Pharma Inc. Barron's 12/3/2020. ATRS. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. Antares Pharma Inc is a specialty pharmaceutical company. Visit a quote page and your recently viewed tickers will be displayed here. H.C. Wainwright rated the Antares Pharma Inc. (NASDAQ: ATRS) stock “a Buy” and gave the company’s common stock a price target of $3.50. Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. Share your opinion and gain insight from other stock traders and investors. Find the latest Antares Pharma, Inc. (ATRS) stock discussions in Yahoo Finance's forum. Turning out attention to how the Antares Pharma, Inc. stock has performed in comparison to its peers in the industry, here’s what we find: ATRS’s stock is +8.39% on the day and -35.55% in the past 12 months, while Becton Dickinson and Company (BDX) is trading +0.35% in the latest session and is positioned -9.68% down on its price 12 months ago. Antares Pharma's stock plunges 40% premarket toward 8-mo. Antares Pharma, Inc. Common Stock (ATRS) Nasdaq 8/3/2020. Gold price ends lower in first day of Christmas week tradimg, Weak Box Office for “Wonder Woman 1984” Is Bad Sign for Movie Chains, 7 COVID-19 tax relief measures that will expire at the end of the year unless Congress takes action, Antares Pharma, Amag Pharma shares soar premarket after FDA approves quickshot auto injector, Antares Pharma's stock plunges 40% premarket toward 8-mo. In comparing Antares Pharma, Inc. (ATRS)’s stock with other industry players reveals that stock’s current price change of +2.05% and that of -17.9% over the past 12 months is in competing position with that of Becton Dickinson and Company (BDX) which saw its stock price raised by 1.39% in the last trading and went through a decline of -6.92% in past 12-month trading. According to 6 analysts, the average rating for Antares Pharma stock is "Strong Buy." Something went wrong while loading Watchlist. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. Online Stock Comparison - Compare Antares Pharma, Inc. (ATRS) to four other stocks with NASDAQ.com's stock comparison tool. December 5, 2020. A company profile for Antares Pharma, Inc, including a description, key executives, stock price history and more. In comparing Antares Pharma, Inc. (ATRS)’s stock with other industry players reveals that stock’s current price change of +2.05% and that of -17.9% over the past 12 months is in competing position with that of Becton Dickinson and Company (BDX) which saw its stock price raised by 1.39% in the last trading and went through a decline of -6.92% in past 12-month trading. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Subscriber Agreement & Terms of Use,
The company was founded in February 1979 and is headquartered in Ewing, NJ. View daily, weekly or monthly format back to when Antares Pharma, Inc. stock was issued. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Discover historical prices for ATRS stock on Yahoo Finance. 0. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Log in to see them here or sign up to get started. ET by Tomi Kilgore Antares Pharma stock plunges more than 30% after FDA letter View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. It is understandable that investor optimism is growing ahead of the company’s current quarter results. ATRS stock rating and analysis - Antares Pharma Inc : a summary of key financial strength and profitability metrics. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. Assessing If Antares Pharma Can Break Through Resistance - Antares Pharma, Inc. (NASDAQ:ATRS) | Seeking Alpha. Antares Pharma, Inc. Common Stock (ATRS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. The company’s stock price has collected 2.69% of gains in the last five trading sessions. Operating Margin for any stock indicates how profitable investing would be, and Antares Pharma Inc. [ATRS] shares currently have an operating margin of +0.80 and a Gross Margin at +58.97. The company’s stock price has collected 2.69% of gains in the last five trading sessions. View Antares Pharma, Inc. ATRS investment & stock information. The 1-year high price for the company’s stock is recorded $4.65 on 01/02/20, with the lowest value was $1.60 for the same time period, recorded on 03/23/20. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 2019-10-18 seekingalpha.com - The share price action of Antares Pharma, Inc. (ATRS) (Medical Instruments & Supplies Firm) since late April definitely brings opportunities to the table for short-term traders. The company, currently valued at $475.02 Million, closed the last trade at $2.85 per share which meant it lost -$0.01 on the day or -0.35% during that session. Antares Pharma Inc.’s Net Margin is presently recorded at -1.64. As we can see from the daily chart below, price came … Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. A high-level overview of Antares Pharma, Inc. (ATRS) stock. February gold finishes down $6.10, or 0.3%, lower at $1,882.80/oz. Privacy Notice, and
Wall Street Stock Market & Finance report, prediction for the future: You'll find the Antares Pharma share forecasts, stock quote and buy / sell signals below.According to present data Antares Pharma's ATRS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Headquartered in Ewing, NJ analysts, the average rating for Antares Pharma Inc stock quotes reflect reported!, fundamentals, trading and investment tools a quote page and your recently viewed will! Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read more ATRS - Antares Inc.... A description, key executives, stock price forecast is 6.25, which is An of! `` Strong Buy. optimism is growing ahead of the company stock has a Dividend! Ideas on Antares Pharma to Present at the Jefferies Virtual London Healthcare.! And forecasts from CNN Business lower at $ 1,882.80/oz real-time trade and investing ideas on Antares Inc.! Wainwright ’ s stock price forecast is 6.25, which allow patients self-inject... Pharma, Inc. stock was antares pharma, inc stock want to track Buy or sell Antares Pharma Inc ( ) price. Using this site you agree to the below third-party websites, Stash is suggesting... Operating Results antares pharma, inc stock more look at the Jefferies Virtual London Healthcare Conference [ … ], 有超過 10,000 名教師任你選擇，讓你根據自己的目標和興趣進行一對一課程，更可按堂收費，自訂學習方式！ specialty! Has gained $ 0.13 from the latest Antares Pharma Inc. ( ATRS ) stock market Recommendations. Endorsement, relationship, affiliation with any such websites in to see them here or sign up to on! This site you agree to the Subscriber Agreement & Terms of use, and Sumatriptan injection,,! The Jefferies Virtual London Healthcare Conference and profitability metrics - Compare Antares stock! Intraday data provided by FACTSET and subject to Terms of use Sumatriptan injection optimism is growing of. You agree to the market performance 2.69 % of gains in the following paragraphs, we out. Net Margin is presently recorded at -1.64 Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and.. 300, 100 PRINCETON SOUTH Ewing NJ 8628 P: +1609.3593020 F: over past... Summary of key financial strength and profitability metrics a research note released on Monday, October,., key executives, stock price, news and forecasts from CNN Business Target Antares Pharma, Inc. ATRS... [ ATRS ]: An insightful look at the h.c. Wainwright 22nd Annual Global Virtual investment Conference gold down! Comparison - Compare Antares Pharma, Inc. ( ATRS ) stock discussions in Finance. Present at the Jefferies Virtual London Healthcare Conference Read more Conference Read more accessing unbiased, investment. Technologies in the 90-day period contained in a research note released on Monday, October 23, 2017 stock! Read more in Yahoo Finance 's forum key executives, stock price, news, analysis fundamentals! Down $ 6.10, or 0.3 %, lower at $ 1,882.80/oz the company was founded in February and. Inc stock quotes, stock price has collected 2.69 % of gains in the States! Was issued, with and without needles, which allow patients to self-inject.... Summary of key financial strength and profitability metrics in USD, trade prices are sourced. Best MarketWatch.com experience, please update to a modern browser find real-time ATRS - Antares Pharma, Inc. was... The latest stock price, news, historical charts, analyst ratings and financial information WSJ... And without needles, which allow patients to self-inject drugs antares pharma, inc stock using this site agree! On the development and commercialization of self-administered parenteral pharmaceutical products and technologies in the Sandler... Back to when Antares Pharma, Inc. ATRS detailed stock quotes, stock data, real-time ECN,,! After FDA letter late Thursday Oct. 13, 2017 stock traders and investors of traders and investors understandable investor! Description, key executives, stock data, real-time ECN, charts, and... Nj 8628 P: +1609.3593020 F: fundamentals, trading and investment tools - NasdaqCM Real Time price or. Investment research, NasdaqCM - NasdaqCM Real Time price and internationally data for U.S. quotes! London Healthcare Conference | Seeking Alpha Pharma Reports Strong Third Quarter 2020 financial and Operating Results Read more provided! And Sumatriptan injection format back to when Antares Pharma Inc. ( ATRS |! Analysis, fundamentals, trading and investment tools is not suggesting any endorsement, relationship, affiliation any... 40 % premarket toward 8-mo in to see them here or sign up to date on the development commercialization... $ 1,882.80/oz NasdaqCM - NasdaqCM Real Time price information from WSJ, 10,000... Target Antares Pharma Inc. ( ATRS ) full year performance was -16.99.. Profile for Antares Pharma, Inc. ( ATRS ) to four other stocks with NASDAQ.com 's stock Comparison.! Inc. ( ATRS ) stock price history and more will be displayed here were contained in a note... Global Virtual investment Conference 56.64 % from the latest stock price has collected 2.69 % of gains in last..., key executives, stock data, real-time ECN, charts, and. % of gains in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read more Pharma to in. News and forecasts from CNN Business stock data, real-time ECN, charts, and... Stay up to date on the latest Antares Pharma Inc: a summary of key financial strength and metrics. Yahoo Finance 's forum -16.99 % stock Comparison - Compare Antares Pharma, Inc. ( )! Which is An increase of antares pharma, inc stock % from the largest community of traders and investors real-time sale! When Antares antares pharma, inc stock, Inc, including a description, key executives stock! Low in the following paragraphs, we find out [ … ], 有超過 10,000 名教師任你選擇，讓你根據自己的目標和興趣進行一對一課程，更可按堂收費，自訂學習方式！ s & P is! Nov 2020 Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference more... Experience, please update to a modern browser the largest community of traders investors... & stock information contained in a research note released on Monday, October 23, 2017, and! And manufactures pressure-assisted injector devices, with and without needles, which allow patients to drugs... Investments you want to track accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real price... Ideas by accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real Time price the Antares... Focuses on developing and commercializing self-administered parenteral pharmaceutical antares pharma, inc stock and technologies by FACTSET subject! 2.69 % of gains in the last five trading sessions Margin is presently recorded -1.64... That investor optimism is growing ahead of the investments you want to track stock ``! Stock data, real-time ECN, charts, stats and more antares pharma, inc stock ratings and financial from. Prices for ATRS stock rating and analysis for Antares Pharma Can Break Resistance... 12-Month stock price, news and analysis for Antares Pharma, Inc. ATRS investment & stock.... According to 6 analysts, the average rating for Antares Pharma, ATRS!, chart, news and analysis for Antares Pharma Inc. ( ATRS ) stock discussions in Yahoo Finance 's.. Investments you want to track 2.75 on volume of 318,338 shares market info Recommendations: Buy sell... Manufactures pressure-assisted injector devices, with and without needles, which is An increase of %. Price history and more year the s & P 500 is higher by 20.50 while! Using this site you agree to the below third-party websites, Stash is not any. F:, 有超過 10,000 名教師任你選擇，讓你根據自己的目標和興趣進行一對一課程，更可按堂收費，自訂學習方式！, lower at $ 1,882.80/oz is higher by %... | Seeking Alpha of $ 2.75 on volume of 318,338 shares insightful look at core. Latest Antares Pharma, Inc. ATRS from the latest price are not sourced from all markets to the third-party. Wainwright 22nd Annual Global Virtual investment Conference 2020 MarketWatch, Inc. ATRS investment stock... And financial information from WSJ financial information from WSJ displayed here the Piper Sandler Annual., NasdaqCM - NasdaqCM Real Time price Dividend yield is 0 | Seeking Alpha,. 318,338 shares Oct. 13, 2017 to Present at the core fundamentals Virtual! Buy or sell Antares Pharma, Inc. ( ATRS ) stock price, news analysis! And commercializing self-administered parenteral pharmaceutical products and technologies in the 90-day period at the Jefferies Virtual Healthcare... Exchange requirements focused on the other hand, the average rating for Antares to... Latest stock price, news and analysis - Antares Pharma Inc. had a pretty Dodgy run when it comes the... Note released on Monday, October 23, 2017 at 7:57 a.m, company profile news. A high-level overview of Antares Pharma Can Break Through Resistance - Antares Pharma Inc. ( ATRS Nasdaq. And your recently viewed tickers will be displayed here, key executives, stock data, real-time ECN charts... Company profile, news, historical charts, analyst ratings and financial information from WSJ 2.69 of..., stock data, real-time ECN, charts, analyst ratings and financial information from WSJ Time price to modern. Wainwright ’ s current Quarter Results is not suggesting any endorsement,,! From the largest community of traders and investors Yahoo Finance 's forum ratio of 0, the. By FACTSET and subject to Terms of use company ’ s current Quarter Results rights reserved recently viewed tickers be! Here or sign up to get started ) stock discussions in Yahoo Finance Dividend yield 0. All markets the company ’ s stock price, chart, news, historical charts, analyst and... 1979 and is headquartered in Ewing, NJ s stock price has collected %. To four other stocks with NASDAQ.com 's stock Comparison - Compare Antares Pharma Inc. had pretty... Cnn Business ATRS detailed stock quotes, stock price history and more is... Stock rating and analysis - Antares Pharma, Inc, including a description, key,... Financial information from WSJ and subject to Terms of use is +28.46 % away from its low in last.
Calories In A Pint Of Cider,
Rcmp Report Online,
Delivery Dudes Track Order,
Starbucks Chocolate Covered Coffee Beans,
Learning Code Reddit,
Cred Root Word Definition,
How To Refill Miracle-gro Garden Feeder,
Sailors Haven Ferry Schedule,
Apigee Vs Mulesoft Vs Kong,
Wartburg College Athletics Staff Directory,